Cargando…
Detection and Differentiation of Breast Cancer Sub-Types using a cPLA2α Activatable Fluorophore
Cytosolic phospholipase A2α (cPLA2α) has been shown to be elevated in breast cancer and is a potential biomarker in the differentiation of molecular sub-types. Using a cPLA2α activatable fluorophore, DDAO arachidonate, we explore its ability to function as a contrast agent in fluorescence-guided sur...
Autores principales: | Chiorazzo, Michael G., Tunset, Hanna Maja, Popov, Anatoliy V., Johansen, Berit, Moestue, Siver, Delikatny, E. James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467920/ https://www.ncbi.nlm.nih.gov/pubmed/30992473 http://dx.doi.org/10.1038/s41598-019-41626-y |
Ejemplares similares
-
Cytosolic Phospholipase A2 Alpha Regulates TLR Signaling and Migration in Metastatic 4T1 Cells
por: Tunset, Hanna Maja, et al.
Publicado: (2019) -
cPLA(2)α Enzyme Inhibition Attenuates Inflammation and Keratinocyte Proliferation
por: Ashcroft, Felicity J., et al.
Publicado: (2020) -
Novel role of cPLA(2)α in membrane and actin dynamics
por: Moes, Maarten, et al.
Publicado: (2010) -
Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model
por: Kim, Eugene, et al.
Publicado: (2016) -
Activatable Fluorophores for Imaging Immune Cell Function
por: Mendive-Tapia, Lorena, et al.
Publicado: (2022)